| Product NDC: | 42747-222 |
| Proprietary Name: | Abstral |
| Non Proprietary Name: | fentanyl |
| Active Ingredient(s): | 200 ug/1 & nbsp; fentanyl |
| Administration Route(s): | SUBLINGUAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 42747-222 |
| Labeler Name: | ProStrakan, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022510 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110107 |
| Package NDC: | 42747-222-32 |
| Package Description: | 32 TABLET in 1 BLISTER PACK (42747-222-32) |
| NDC Code | 42747-222-32 |
| Proprietary Name | Abstral |
| Package Description | 32 TABLET in 1 BLISTER PACK (42747-222-32) |
| Product NDC | 42747-222 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fentanyl |
| Dosage Form Name | TABLET |
| Route Name | SUBLINGUAL |
| Start Marketing Date | 20110107 |
| Marketing Category Name | NDA |
| Labeler Name | ProStrakan, Inc. |
| Substance Name | FENTANYL CITRATE |
| Strength Number | 200 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |